Table 3.

MiR-15a-5p, miR-126-3p, miR-142-5p, miR-21-5p and miR-150-5p in group with Graves’ disease (GD) compared to group with Hashimoto’s thyroiditis (HT).

	Patients with GD (n = 25)	Patients with HT (n = 26)
miR-15a-5p	21.61 amol/µL	49.15 amol/µL (p = NS)
miR-126-3p	7.09 amol/µL	7.31 amol/µL (p = NS)
miR-142-5p	3.8 amol/µL	3.7 amol/µL (p = NS)
miR-150-5p	1.07 amol/µL	1.08 amol/µL (p = NS)
miR-21-5p	2.16 amol/µL	2.58 amol/µL (p = NS)

p—p-value; NS—statistically non-significant—p-value > 0.05; p-correlation between group of patients with GD compared to group with HT.